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Abstract
Background: The WHO Maternal Near Miss (MNM) approach was developed to evaluate and improve quality of
obstetric care worldwide. This study aimed to study the incidence of MNM and quality of care at a district hospital
in rural Rwanda by applying this approach.
Methods: A facility based, prospective cohort study conducted at a district hospital in rural Rwanda between June
2013 and December 2014. Subjects were followed from time of admission to discharge or death.
Results: In 3979 deliveries, 3827 singletons and 152 twins pairs were born. Among the 4131 neonates, there were
3994 live births and 137 stillbirths. Ninety-nine women suffered severe maternal outcome (SMO): 86 maternal near
misses and 13 deaths. This adds up to a maternal near miss ratio of 21.5 per 1000 live births (95 % CI 17.3-26.5), a
maternal mortality ratio of 325 per 100 000 live births (95 % CI 181–543) and a mortality index of 13.1 % (95 % CI
7.3–21.9). Hemorrhage (n = 49, 57 %) and hypertensive disorders (n = 27, 31.4 %) were the commonest MNM conditions.
Eclampsia (n = 4/13; 30.7 %) was the leading cause of maternal mortality, while sepsis/peritonitis following
cesarean section (n = 2/6; 33.3 %) had the highest mortality index. Seventy-seven out of 99 SMO cases (77.9 %)
were referred from other facilities with critical conditions and 28 out of 99 SMO cases (28.3 %) were admitted
into the Intensive Care Unit. Several indicators such as administration of oxytocin, magnesium sulfate and
antibiotics were found to be suboptimal.
Conclusions: MNM is common at district level in Rwanda. The MNM approach enabled us to identify shortfalls
in clinical practice and the referral system.
Keywords: Audit, Maternal morbidity, Maternal mortality, Maternal near miss, Obstetrics, Quality of care
Background
Most maternal deaths occur during the intrapartum and
immediate postpartum period from preventable or treat-
able causes such as hemorrhage, eclampsia and sepsis
[1]. The majority of these women die in low-income
countries, and several countries in sub-Saharan Africa
have very high maternal mortality ratios (MMR), often
double the estimated global MMR of 400 per 100,000
live births [2].
Although global and regional population based num-
bers of maternal deaths remain high, numbers at the
facility level are relatively low. It has been shown that
reviewing critical incidents, including obstetric audits
at facility level, may improve quality of facility based
care [3] and functioning of the broader health system
[4–6].
Until recently, a variety of criteria was used to define
severe maternal morbidity or maternal near miss (MNM)
[4]. In 2011, the World Health Organization (WHO)
developed a systematic MNM approach. The aim was
to facilitate comparisons between different studies, and
between countries and regions [7], in order to address
shortcomings in quality of obstetric care and improve
pregnancy outcome [8]. Within this approach, an
MNM refers to ‘a woman who almost died but survived
a complication during pregnancy, childbirth, or within
42 days after termination of pregnancy’ [9, 10], and
organ failure based criteria reflect critical illness and
allow for identification of MNM. A number of studies
* Correspondence: kalichard@gmail.com
1Department of Obstetrics and Gynecology, Ruhengeri Hospital, Musanze,
Rwanda
2Athena Institute, VU University, Amsterdam, The Netherlands
Full list of author information is available at the end of the article
© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Kalisa et al. BMC Pregnancy and Childbirth  (2016) 16:324 
DOI 10.1186/s12884-016-1119-1
have applied these criteria in low-income countries
[8, 11–14].
In Rwanda, the MMR has been reduced by roughly
two-thirds from 750 in 2005 to 210 per 100 000 live
births in 2015 [15, 16]. This may have resulted from
strong government commitment combined with a
well-organized community based health program, per-
formance based financing, innovative community health
insurance, and SMS-based alert systems among other pol-
icy changes [17, 18]. Nevertheless, additional progress is
needed, and evaluation of MNM may be of increasing use
in light of this mortality reduction. This study aimed to
assess MNM characteristics and process indicators related
to quality of care at a district hospital in rural Rwanda, by
applying the WHO MNM approach.
Methods
This was a prospective cohort study among pregnant
women who were admitted for delivery or pregnancy re-
lated complications, and who sustained severe acute mater-
nal morbidity at Ruhengeri maternity ward in Musanze
district, Rwanda, between June 2013 and December 2014.
Musanze is located in northern Rwanda, at 94 km from the
capital Kigali, and has a population of 368 267 inhabitants
with a total fertility rate of 4.6 births per woman [16].
Ruhengeri hospital acts as a provincial referral hospital
for high-risk obstetric cases from health centers and
other district hospitals in the northern province. Annu-
ally, 3500 deliveries are conducted at the facility. During
the study period, medical staff consisted of one specialist
obstetrician, four medical officers, two intern doctors
and 18 midwives. Patients with critical conditions were
admitted into the intensive care unit (ICU), where vital
signs were monitored hourly, and treatment with vaso-
active drugs and mechanical ventilation could be pro-
vided. Blood for transfusion was supplied by the regional
blood bank located next to the hospital.
Eligibility for the study was not restricted by gesta-
tional age. Therefore, women who had had an abortion
or ectopic pregnancy and met the WHO MNM criteria
were also included [7, 10]. Women who developed
complications more than 42 days after termination of
pregnancy were not eligible. On a daily basis, we cap-
tured relevant data for every woman who presented
with severe acute maternal morbidity or died during
admission, by using available medical records. Severe
Maternal Outcome (SMO) was defined as MNMs and
maternal deaths combined.
Two trained research assistants screened possible
participants and the principal investigator (RK) verified
suitability for study inclusion. Possible participants
included patients who had severe maternal complica-
tions at baseline, received critical interventions or were
admitted into the ICU, according to WHO guidelines
[10]. We tried as much as possible to apply the WHO
MNM criteria but had to make several modifications
due to lack of laboratory tests and management options
(Table 1). For every case, information was collected re-
garding socio-demographic characteristics, gestational
age, maternal and neonatal outcome, as well as process
indicators regarding prevention and treatment of the
main causes of MNM and death: giving magnesium sul-
fate for treatment of eclampsia, oxytocin for prevention
and treatment of postpartum hemorrhage, and antibiotics
for prophylaxis (during cesarean section) and treatment of
sepsis.
Data were entered into Microsoft Excel, and subse-
quently entered into STATA version 12 for analysis. Out-
comes were given in proportions with 95 % confidence
intervals (CIs). The results are presented in accordance
with the WHO MNM approach.
Results
During the 19-month study period, there were 3979 de-
liveries, in which 3827 singletons and 152 twins pairs
were born. Among the 4131 neonates, there were 3994
live births, and 137 stillbirths. Three hundred thirty two
women sustained potentially life-threatening conditions
and 99 had SMO: 86 near misses and 13 maternal
deaths. The cesarean section rate for Ruhengeri hospital
was 34.9 %.
Cases of morbidity were classified by underlying
causes and type of organ system dysfunction (Tables 2
and 3). The commonest conditions contributing to
MNM were severe hemorrhage (n = 49; 57 %), but with
MI 5.8 % (95 % CI 1.5–15.7). Severe hypertensive dis-
orders was the second main cause of morbidity (n =
27; 31.4 %) with MI 13 % (95 % CI 4.1–31.1). Eclamp-
sia (n = 4/13; 30.7 %) was the leading cause of maternal
mortality, while sepsis/peritonitis following cesarean
section (n = 2/6; 33.3 %) had the highest mortality
index. Other common contributing factors among
MNM cases were lack of health insurance (n = 23;
26.7 %), anemia (n = 21; 24.4 %) and previous cesarean
section (n = 12; 14 %).
Most common organ dysfunctions among women
with MNM conditions were cardiovascular dysfunction
(n = 56; 65.1 %) followed by multiple organ dysfunction
(n = 35; 40.7 %). The mortality index was highest for
hepatic dysfunction, (33.3 %). The MNM/mortality ra-
tio was highest for cardiovascular dysfunction (8:1),
followed by renal and neurologic dysfunction (5:1)
(Table 3).
Cesarean section was performed in many women with
potentially life threatening conditions (n = 125/332;
37.7 %), MNM (n = 37/86; 43 %) and maternal deaths
(n = 3/13; 23.1 %). Neonatal outcomes (preterm births,
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stillbirths and perinatal deaths) were worst among ma-
ternal deaths and comparable between women with po-
tentially life threatening conditions and maternal near
misses (Table 4).
The SMO ratio was 24.8 per 1000 live births (95 % CI
20.3–30.1), and the MNM ratio 21.5 per 1000 live births
(95 % CI 17.3–26.5). The maternal mortality ratio
(MMR) was 325 (95 % CI 181–543) per 100 000 live
births, the mortality index (MI =maternal deaths/MNM
+ maternal deaths) 13.1 % (95 % CI 7.3–21.9), and the
maternal near miss mortality ratio (MNM: maternal
deaths) 7:1 (Table 5). In 332 women, 234 critical inter-
ventions were carried out, including 108 blood transfu-
sions (32.5 % of women) and 71 laparotomies (21.4 % of
women). The ICU admission rate was 1.4 % (61/4353)
among all women, whereas ICU admission rate among
women with SMO was 28.3 % (28/99) and proportion of
maternal deaths occurred without ICU admission was
46 % (6/13) (Table 5). Of 134 women with severe
hemorrhage, 52 (38,8 %) were transfused five or more
units of blood.
Among women with SMO, oxytocin was given in 3862
women (93.5 %) for prevention of postpartum
hemorrhage, and only 97 of 134 women with severe
PPH (72.4 %) received oxytocin as treatment. Almost all
women with eclampsia (52/53; 98.1 %) received magne-
sium sulphate. Intra-operative prophylactic antibiotics were
Table 1 WHO near miss criteria and modifications for Ruhengeri
hospital
WHO near miss criteria [10] Ruhengeri near
miss criteria
Clinical Criteria
Acute Cyanosis Not modified
Gasping Not modified
Respiratory rate > 40 or < 6/min Not modified
Shocka Not modified
Oliguria non responsive to fluids or diureticsb Not modified
Failure to form clotsc Not modified
Loss of consciousness lasting > 12 hd Not modified
Cardiac arreste Not modified
Strokef Not modified
Uncontrollable fit/total paralysisg Not modified
Jaundice in the presence of pre-eclampsiah Not modifiedi
Laboratory-based criteria
Oxygen saturation < 90 % for ≥ 60 min Not modified
PaO2/FiO2, 200 mmHg Not availablej
Creatinine ≥300 mmol/l or ≥ 3.5 mg/dL Not modified
Bilirubin > 100 mmol/l or .6.0 mg/dL Not modified
pH < 7.1 Not available
Lactate > 5 mEq/mL Not available
Acute thrombocytopenia (< 50,000 platelets/ml) Not modified
ketoacids in urine Not available
Management-based criteria
Admission to intensive care unit Not modified
Use of continuous vasoactive drugs Not modified
Hysterectomy following infection or hemorrhage Not modified
Transfusion of ≥ 5 units of blood Not modified
Intubation and ventilation for ≥ 60 min not
related to anesthesia
Not modified
Dialysis for acute renal failure Not available
Cardio-pulmonary resuscitation Not modified







aShock is defined as a persistent severe hypotension, defined as a systolic
blood pressure < 90 mmHg for 60 min with a pulse rate of ≥ 120/min despite
aggressive fluid replacement (> 2 L)
bOliguria is defined as an urinary output < 30 ml/h for 4 h or < 400 ml/24 h
cFailure to form clots is defined as the absence of clotting from the IV site
after 7–10 min
dUnconsciousness/coma lasting > 12 h is defined as a profound alteration of
mental state that involves complete or near-complete lack of responsiveness
to external stimuli or Glasgow Coma Scale < 10
eCardiac arrest is defined as loss of consciousness and absence of pulse or heart beat
fStroke is defined as a neurological deficit of cerebrovascular cause that
persists ≥ 24 h, or is interrupted by death within 24 h
gUncontrollable fit is a condition in which the brain is in state of
continuous seizure
hPre-eclampsia: the presence of hypertension associated with proteinuria.
Hypertension is defined as a blood pressure≥ 140 mmHg (systolic) or≥ 90 mmHg
(diastolic). Proteinuria is defined as excretion of≥ 300 mg protein/24 h or 300 mg
protein/l urine or ≥ 1+ on a dipstick
iWas not regularly available due to lack of resources
jNot available
kEclampsia is defined as the presence of hypertension associated with
proteinuria and fits
lSepsis is defined as a clinical sign of infection and 3 of the following:
temp> 38C or < 36C, respiration rate > 20/min, pulse rate > 90/min, WBC > 12,
clinical signs of peritonitis
mUterine rupture is defined as the complete rupture of a uterus during labor
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Table 2 Underlying causes and contributory factors of potentially life-threatening conditions (PLTC) and severe maternal outcomesa
Women with PLTC MNM Maternal deaths MNMR/1000 live birth Mortality index
332 (%) 86 (%) 13 (%) (%)
Underlying causesb
Severe hemorrhage 134 (40.4) 49 (57) 3 (23.1) 12.3 (9.2–16.1) 5.8 (1.5–15.7)
Abortion 33 (9.9) 7 (8.1) 0 (0)
Ectopic 21 (6.3) 13 (15.2) 0 (0)
Molar 4 (1.2) 0 (0) 0 (0)
Placental abruption 10 (3.0) 4 (4.6) 0 (0)
Placenta Previa 17 (5.1) 6 (7.0) 0 (0)
Postpartum Hemorrhage 49 (14.8) 19 (22.1) 3 (23.1)
Hypertensive disorders 93 (28.0) 27 (31.4) 4 (30.7) 6.8 (4.6–9.7) 13 (4.1–31.1)
Severe Pre-eclampsia 40 (43.0) 7 (8.1) 0 (0) –
Eclampsia 53 (57.0) 20 (23.3) 4 (30.7)
Pregnancy related infectionsc 40 (12.1) 0 (0) 2 (15.4) –
Sepsis/peritonitis post-cesarean 38 (11.4) 4 (4.7) 2 (15.4) 1.0 (0.3–2.4) 33.3 (5.6–110.1)
Unanticipated complications of managementd 0 (0) 2 (2.3) 1 (7.7) 0.5 (0.1–1.7) 14.3 (1.6–164.4)
Coincidental conditionse 2 (0.6) 0 (0) 0 (0.0) –
Unknown 0 (0) 0 (0) 1 (7.7) –
Other obstetric complicationsf 16 (4.8) 4 (4.7) –
Associated conditions
Anemia 73 (22) 21 (24.4) 4 (30.8) 5.3 (3.3–7.9) 16.0 (5.1–38.6)
HIV 16 (4.8) 8 (9.3) 2 (15.4) 2.0 (0.9–3.8) 20.0 (3.3–66.1)
Previous CS 22 (6.6) 12 (14) 1 (7.7) 3.0 (1.6–5.1) 7.7 (0.3–37.9)
Prolonged/obstructed Labor 5 (1.5) 5 (5.8) 1 (7.7) 1.3 (0.5–2.8) 16.7 (0.8–82.2)
Lack of medical Insurance 28 (8.4) 23 (26.7) 4 (30.8) 5.8 (3.7–8.5) 14.8 (4.7–35.7)
aValues given as number (percentages)
bOne woman could have experienced more than one cause
cPyelonephritis (12 PLTC), Hyperemesis (10 PLTC), Choriamnionitis (8 PLTC), Endometritis (8 PLTC), severe malaria (2 PLTC, 1 MD), HIV encephalopathy (1 MD)
dIatrogenic complications (2 MNM, 1 MD)
eRoad traffic accident, Stevens-Johnson syndrome (2 PLTC)
fAsthmatic crisis (6 PLTC), Herbal intoxication (4 PLTC), Epilepsy (3 PLTC, 1 MNM), Unknown cause of Jaundice (2 PLTC), Blood transfusion reaction (1 PLTC, 1MNM),
Peripartum cardiomyopathy (2 MNM)
Table 3 Frequencies of maternal near miss and maternal death by type of organ system dysfunction
Organ dysfunctions MNM cases n = 86 (%) Maternal death n = 13 (%) MNM mortality ratio Mortality index (%) 95 % CI
Cardiovascular 56 (65.1) 7 (53.8) 8 :1 11.1 (4.9–21.)
Renal 5 (5.8) 1 (7.7) 5 :1 16.7 (0.8–82.2)
Respiratory 25 (29.1) 6 (46.2) 4 :1 19.4 (7.9–40.3)
Hepatic 6 (7.0) 3 (23.1) 2 :1 33.3 (8.5–90.7)
Neurologic 26 (30.2) 5 (38.5) 5 :1 16.1 (5.9–35.8)
Hematologic 16 (18.6) 7 (53.8) 2 :1 30.4 (13.3–60.2)
Hysterectomy/Uterine 8 (9.3) 3 (23.1) 3 :1 27.3 (6.9–74.2)
Multiple organ 35 (40.7) 9 (69.2) 4 :1 20.5 (9.9–37.5)
Unspecified organ – 2 (15.4) –
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administered to 1409 out of 1442 women (97.7 %) who de-
livered by cesarean section. Only 18 of 38 women (47.4 %)
with sepsis received parenteral antibiotics (Table 6).
Discussion
This is the first study of SMO at a district hospital in
rural Rwanda. The high prevalence of MNM in our
study lies within the wide range of ratios reported in
studies from other low-income countries, which used
similar near miss criteria [11, 19, 20]. The high MNMR
of 21.5 per 1000 live births in our study may be ex-
plained by: i) different interpretations of the criteria
[12–14], ii) delayed referral of SMO cases (77.9 % com-
pared to 20.9–64.4 % in the other studies) or iii) the high
proportion of women without medical insurance which
may have led to delay in seeking or providing care. The
higher mortality index for MNM of 13.1 % in our and
similar studies from Africa [8, 13, 14] compared to
middle-income countries [5], demonstrates that a larger
number of critically ill women in low-resource settings
die from such severe complications.
The main direct causes of SMO were obstetric
hemorrhage and hypertensive disorders, comparable to
other studies in low-resource countries [11–14]. Mortal-
ity indices for these conditions were lower than in other
studies, probably due to wide availability of blood for
transfusion and magnesium sulfate in our setting. Par-
ticular attention is needed for conditions with a high
mortality index, in particular post-cesarean sepsis and
peritonitis, which were previously reported to also be a
problem at a tertiary hospital in Rwanda [14]. The rela-
tive inexperience from medical officers working in
district hospitals (generally recent medical school
graduates) may compound this problem [21], combined
with improper use of antibiotics and poor sterilization
procedures [22]. These findings are extremely worrying
in light of the very high cesarean section rate. This rate
calls for rigorous audit of cesarean section indications
[23].
Two-thirds of SMO cases were received in critical
condition from other facilities or home. This may indi-
cate difficulties in the referral system or detection of
pregnant women with life threatening complications
outside health facilities due to delays in seeking or
reaching care [19]. Women who were referred consti-
tuted the large majority of all women with SMO. It also
addresses quality of care in lower-level health facilities.
When analyzing access to care, it is essential to separate
near miss cases on arrival from those developing in the
hospital. This would be unexpectedly high given the gov-
ernment’s commitment towards improving maternal and
neonatal health care through use of its existing programs
[17, 18] to reduce first and second delays [24]. This
highlights a number of potential interventions, such as
educating pregnant women and their caretakers on ob-
stetric danger signs [21] and training health care workers
at lower level facilities in emergency obstetric care [25].
MNM developed in one quarter of women with poten-
tially life threatening conditions, with high MNMRs due
to cardiovascular, renal and neurologic dysfunction. Sub-
optimal use of some evidence-based practices explains
these SMO cases. The use of uterotonic drugs to prevent
PPH was high; however, less than three out of four
women who developed PPH received oxytocin as a treat-
ment. Similarly, use of prophylactic antibiotics for
cesarean delivery was high; however, less than half of










3922 332 86 13 4353
End of pregnancy
Vaginal Delivery 2344 (59.8) 113 (34.1) 18 (20.9) 7 (53.8) 2482 (57.1)
Vacuum Extraction 156 (3.9) 37 (11.1) 0 (0.0) 0 (0.0) 193 (4.4)
Cesarean section 1277 (32.6) 125 (37.7) 37 (43) 3 (23.1) 1442 (33.1)
Complete abortion, vacuum aspiration/curettage 94 (2.4) 33 (9.9) 7 (8.1) 0 (0.0) 134 (3.1)
Laparotomy for ruptured uterus 0 (0.0) 3 (0.9) 11 (12.8) 1 (7.7) 15 (0.3)
Women discharged or died still pregnant 17 (0.4) 0 (0.0) 0 (0.0) 2 (15.4) 19 (0.4)
Laparotomy for ectopic pregnancy 34 (0.9) 21 (6.3) 13 (15.2) 0 (0.0) 68 (1.6)
Cesarean section ratea n/a (33.8) n/a (45) n/a (56.1) n/a (27.3) n/a (34.9)
Preterm Birth 268 (7.1) 32 (11.5) 5 (7.6) 2 (18.1) 307 (7.4)
Fresh Stillbirth 46 (1.2) 5 (1.8) 6 (9.1) 3 (27.3) 60 (1.5)
Macerated Stillbirth 76 (2.0) 0 (0.0) 0 (0.0) 1 (9.1) 77 (1.9)
Perinatal deathb 107 (2.83) 17 (6.1) 6 (9.1) 5 (45.5) 130 (3.1)
aCesarean deliveries divided by all deliveries/bFetal deaths + intra hospital early neonatal mortality
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women with sepsis received parenteral treatment with
antibiotics. The high patient load at the facility might
have a negative impact on quality of care.
The low number of women with SMO admitted into
ICU is similar to what other authors in low resource set-
tings found [25, 26]. It is easy to under-estimate severe
morbidity in the absence of sophisticated laboratory
diagnostics and shortage of nurse-midwives and clini-
cians to identify clinical signs of deteriorating patients
Table 5 Severe maternal outcomes, near miss indicators and
facility-related indicators, including 95 % confidence intervals
Maternal outcomes and indicatorsa Value
Severe maternal outcomes (SMO) cases (n) 99
Cases of maternal death (n) 13
Cases of maternal near miss (n) 86
Overall near miss indicators
cSevere maternal outcome ratio
(per 1000 live births)
24.8 (20.3–30.1)b
Maternal near miss incidence ratio
(per 1000 live births)
21.5 (17.3–26.5)b
dMaternal near miss mortality ratio 7:1
eMortality index 13.1 % (7.3–21.9)
Hospital access indicatorsb
SMO cases presenting with organ dysfunction
or maternal death within 12 h of
hospital stay (SM012) (n)
79
Percentage of SM012 cases among
all SMO cases
79.8 (63.6–98.9)
Percentage of SM012 cases coming
from other health facilities
77.8 (61.8–96.7)
SM012 mortality index 8.1 (3.6–16.1)
Intra-hospital care
Intra-hospital SMO cases of organ dysfunction
or maternal death after 12 h of hospital stay
32
Rate of intra-hospital SMO (per 1000 live births) 8.0 (5.6–11.2)
Intra-hospital mortality index 15.8 (6.4–32.8)
Intensive care useda
Percentage of ICU admission 1.4 (1.1–1.8)
Percentage of ICU admission among
women with SMO
28.3 (19.2–40.3)
Percentage of SMO among women
admitted to ICU
73.8 (54.5–97.8)
Percentage of maternal deaths occurred
without ICU admission
46.2 (18.7–96)
Abbreviations: ICU intensive care unit or admission also included women who
stayed in the recovery room on the labor ward for longer than 6 h, SMO
severe maternal outcome
aBased on data from all women (n = 4353)
bThe denominator for these 2 indicators is ‘live births’ (n = 3994)
cSMOR Severe Maternal Outcome Ratio: the number of women with life-
threatening conditions (MNM+ MD) per 1000 live births (LB). This indicator gives
an estimate of the amount of care and resources that would be needed in an
area or facility (SMOR =MNM+MD/LB) [10]
dMNMR Maternal near miss mortality ratio: the number of maternal near miss
cases per 1000 live births (MNMR =MNM/LB). Similarly to the SMOR, this
indicator gives an estimation of the amount of care and resources that would
be needed in an area or facility [10]
eMortality Index (MI): the number of maternal deaths divided by the number
of women with life-threatening conditions expressed as a percentage (MI =MD/
MNM+MD). The higher the index the more women with life-threatening
conditions die (low quality of care), whereas the lower the index the fewer
the women with life-threatening conditions die (better quality of care) [10]




Target population: women giving birth in health
facilities
4131
Oxytocin 3862 (93.5 %)
Treatment of severe PPH
Target population: women with severe PPH 134
Oxytocin 97 (72.4 %)
Ergometrine 105 (78.4 %)
Misoprostol 44 (32.8 %)
Other uterotonics 62 (46.3 %)
Removal of retained products 18 (13.4 %)
Artery ligation 7 (5.2 %)
Hysterectomy 4 (2.9 %)
Abdominal packing 8 (5.9 %)
Cases with SMO 52 (38.8 %)
Mortality 3 (2.2 %)
Anticonvulsants for Eclampsia
Target population: women with eclampsia 53
Magnesium sulfate 52 (98.1 %)
Other anticonvulsant 8 (15.1 %)
Any anticonvulsant 53 (100 %)
Cases with SMO 24 (50.9 %)
Mortality 4 (7.5 %)
Prevention of cesarean-related infection
Target population: women undergoing cesarean 1442
Prophylactic antibiotic during cesarean 1409 (97.6 %)
Treatment for sepsis
Target population: women with sepsis 38
Parenteral therapeutic antibiotics 18 (47.4 %)
Cases with SMO 6 (15.8 %)
Mortality 2 (5.3 %)
Ruptured uterus
Target population: women with ruptured uterus 15
Laparotomy after 3 h of hospital stay 2 (13.3 %)
Cases with SMO 12 (80.0 %)
Mortality 1 (6.7 %)
Abbreviations: PPH postpartum hemorrhage, SMO severe maternal outcome
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[12, 13]. In sub-Saharan African countries, studies have
shown maternal morbidity and mortality can be signifi-
cantly reduced by improving maternal health care when
health workers themselves use audit to identify and
analyze deficiencies and apply the findings to improve
their obstetric care practices [3, 27]. However, our set-
ting is more focused on treating conditions instead of
looking further on how to avoid these in the future. This
type of audit will be initiated at Ruhengeri hospital as it
is paramount to follow-up actions and maternal health
outcomes after an audit [28].
Our study is the first study to be conducted in a rural
setting in Rwanda to assess SMO using the new WHO
MNM criteria. The advantage of this approach is its
standardized methodology, which may allow for a com-
parison of health facilities and systems. Using this ap-
proach led to the integration of regular assessment of
the quality of maternal health care in the hospital. In
terms of limitations, the lack of follow up after discharge
may lead to under reporting of actual MNM and mater-
nal deaths. In addition, the quality of medical records
was sometimes poor. We could not apply all WHO cri-
teria due to limited resources at our facility. Some
women had severe complications, which did not fulfill
any clinical criteria, while laboratory criteria could not
be tested for an important part. This may have caused
additional under estimation of MNM. Autopsies were
not performed and the underlying causes of death were
only based on clinical records. Future longitudinal stud-
ies should be conducted to assess maternal morbidity
and mortality using the WHO approach nationwide.
Interviewing women with MNM may help to elucidate
barriers to receiving hospital care.
Conclusions
In conclusions, MNM is common at district level in
Rwanda. Our study highlights some shortfalls in clinical
practice and the referral system, improvements of which
could lead to further reductions in maternal mortality
and morbidity. We recommend intergrated continous
quality of care interventions by use of audit at all levels
including primary care.
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